INSMED Inc 4
4 · INSMED Inc · Filed Mar 3, 2017
Insider Transaction Report
Form 4
INSMED IncINSM
Drechsler Andrew T
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-03-01$6.65/sh+20,000$133,000→ 25,000 total - Sale
Common Stock
2017-03-01$16.51/sh−20,000$330,200→ 5,000 total - Exercise/Conversion
Stock Option (right to buy)
2017-03-01−20,000→ 74,855 totalExercise: $6.65Exp: 2022-11-07→ Common Stock (20,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-03-01−10,000→ 45,145 totalExercise: $6.65Exp: 2022-11-07→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2017-03-01$6.65/sh+10,000$66,500→ 15,000 total
Footnotes (2)
- [F1]The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.46 to $16.74, inclusive.
- [F2]Stock options granted on November 7, 2012 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.